Overview

Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of pidotimod as treatment in participants with recurrent respiratory tract infections.
Phase:
Phase 4
Details
Lead Sponsor:
Almirall, S.A.
Treatments:
Pidotimod